Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
PRINCETON, N.J., Nov. 11, 2024 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, is proud to announce ...
Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
PRINCETON, N.J., Nov. 11, 2024 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, is proud to announce ...
A chemical injected before MRI scans to help create sharper images may cause some patients to experience a potentially deadly complication in rare cases, a new study suggests. Researchers from the ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
Researchers at The Hong Kong Polytechnic University have developed artificial intelligence (AI) models that generate synthetic MRI scans without the need for gadolinium-based contrast agents, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results